Medical Condition News

RSS

COVID-19 causes lasting cognitive impairment tied to brain injury markers

Researchers found that COVID-19 patients experienced widespread cognitive deficits one year post-hospitalization, associated with elevated brain injury markers and reduced brain volume. Cognitive recovery plateaued over time, suggesting lasting impacts.

26 Sep 2024

Barcoding technology reveals secrets of cancer metastasis

Metastatic cancer can be a devastating diagnosis. The cancer is spreading. It may travel to multiple organs in the body. This could mean more pain and ultimately, death.

26 Sep 2024

Multi-omics analysis reveals mechanism of action for ruthenium-based anti-cancer agent

This study is led by Prof. Cai-Ping Tan, Prof. Zong-Wan Mao (MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University) and Prof. Zheng-Qiu Li (School of Pharmacy, MOE Key Laboratory of Tumor Molecular Biology, Jinan University).

26 Sep 2024

Researchers explore new metabolic pathway to fight cancer

When an aggressive cancer launches an invasion on the human body, anything that can be done to slow down or better understand that fast-paced assault is going to be a bonus.

26 Sep 2024

Foundation receives $100,000 to advance MS care

The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC) recently received a generous donation of $100,000 from EMD Serono Inc., in honor of June Halper, MSN, APN-C, FAAN, MSCN. Ms. Halper a longtime pioneer in the comprehensive care movement for multiple sclerosis (MS), and leading nurse practitioner and MS advocate, passed away on July 24, 2024, at the age of 86, working until her final days as CEO of the CMSC, FCMSC and IOMSN (International Organization of MS Nurses).

26 Sep 2024

New pipeline of drug candidates offers hope for effective MASLD treatments

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), has become the most prevalent chronic liver disease globally.

25 Sep 2024

Study uncovers genetic changes linked to leukemia risk in people with Down's syndrome

People with Down's syndrome face a higher risk of developing Leukemia. Now researchers from the University of Copenhagen and Stanford University explain why, by identifying specific changes in blood cells of people with Down's syndrome.

25 Sep 2024

Research highlights negative brain health outcomes among LGBTQ+ individuals

LGBTQ+ people may be more likely to have negative brain health outcomes, including a higher risk of dementia and late-life depression, than people who are cisgender and straight, according to a study published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

25 Sep 2024

Study reveals life-changing impact of gene therapy for hemophilia B patients

Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the results of an international Phase III clinical trial published today in the New England Journal of Medicine by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group of investigators.

25 Sep 2024

Remote video consultations show positive impact on depression and anxiety

Remote video consultations between patients and mental health specialists show a small but significant improvement on symptoms of depression and anxiety, finds a trial published by The BMJ today.

25 Sep 2024

Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment

The safety and effectiveness of donanemab - an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA) - is called into question in an investigation published by The BMJ today.

25 Sep 2024

New biomarker profiling enhances early detection of melanoma

Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis and prognosis by identifying the disease at its earliest, most treatable stages.

25 Sep 2024

Breakthrough research offers hope for improved treatment of chronic wounds

Novel research, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, has identified key molecular targets that could significantly enhance the healing of both acute and chronic wounds.

25 Sep 2024

Research questions effectiveness of MS medications in slowing disability progression

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receiving treatment.

25 Sep 2024

Study sheds light on mechanisms behind liver fibrosis and potential therapies

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel treatment approach for this common and serious condition.

25 Sep 2024

Wrist-based sensors provide insights into sunlight’s impact on depression

Wrist-based activity sensors worn by individuals with depression and those without over the course of two weeks provided evidence for the relationship between daily sunlight exposure and physical activity, according to a study published September 25, 2024, in the open-access journal PLOS Mental Health by Oleg Kovtun and Sandra Rosenthal from Vanderbilt University, U.S.

25 Sep 2024

Stool-based testing offers a new hope for global colorectal cancer screening

"Stool-based test offers a promising solution to reduce the burden of a colonoscopy," experts emphasized on September 21st, during the ICG 19 · Metagenomics for Health (ICG19·MH) & The 2nd MOHA Consortium. The conference was held in Harbin, Heilongjiang Province of China.

25 Sep 2024

Medical Condition News

COVID-19 causes lasting cognitive impairment tied to brain injury markers

Barcoding technology reveals secrets of cancer metastasis

Multi-omics analysis reveals mechanism of action for ruthenium-based anti-cancer agent

Researchers explore new metabolic pathway to fight cancer

Foundation receives $100,000 to advance MS care

New pipeline of drug candidates offers hope for effective MASLD treatments

Study uncovers genetic changes linked to leukemia risk in people with Down's syndrome

Research highlights negative brain health outcomes among LGBTQ+ individuals

Study reveals life-changing impact of gene therapy for hemophilia B patients

Remote video consultations show positive impact on depression and anxiety

Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment

New biomarker profiling enhances early detection of melanoma

Breakthrough research offers hope for improved treatment of chronic wounds

Research questions effectiveness of MS medications in slowing disability progression

Study sheds light on mechanisms behind liver fibrosis and potential therapies

Wrist-based sensors provide insights into sunlight’s impact on depression

Stool-based testing offers a new hope for global colorectal cancer screening

Study: Obstructive sleep apnea may be a risk factor for abdominal aortic aneurysms

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Older adults face higher CVD risk post-cancer treatment

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News